Seed Biopharma Companies

Peptaris develops AI-driven platforms for discovering and designing therapeutic peptides.

Axio BioPharma is a biotechnology and biomanufacturing company that provides biologics development for biopharmaceutical production.

GevRx Nutraceuticals is a biotechnology company currently operating in stealth mode.

AbTx is a biotech firm developing next-generation antibody-drug conjugates with enzymatic precision for oncology.

Launch Bioindustries is a biotechnology firm that develops sustainable biomaterials using fermentation technology.

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

Clinical decision support platform for pharmacogenomics, medication safety, and real-world evidence.

Cloverleaf Bio develops an RNA therapeutic platform for oncology.

PanTarg develops antibody-drug conjugates for pancreatic cancer and other solid tumors.

Flip Therapeutics develops in vivo immune cell reprogramming therapies for chronic autoimmune and inflammatory diseases.

Redefining drug development. Replicating human tissues.

Platform Therapeutics develops therapies for chemotherapy toxicities and dialysis-related muscle cramps.

LifeCyte Innovations develops therapies targeting chronic inflammation to slow age-related diseases, including AMD and cognitive decline.

K2 Therapeutics creates advanced antibody-based therapies focused on difficult multi-pass membrane targets to address unmet disease needs.

B1 Health offers a platform for clinical trial design optimization, documentation, process tracking & insight generation for biotech firms.

Houdini Bio develops computational synthetic biology tools to redesign DNA constructs for improved genetic medicines.

Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.

FinalDose develops programmable DNA therapeutics that eliminate diseased cells by targeting pathogenic genetic sequences.

BioStack is a digital platform that provides healthcare AI training environments and curated multimodal clinical datasets.

Protuoso Biosciences develops next-generation multifunctional biologics designed to address complex disease biology.

Reprogram Biosciences is a biotechnology company that develops cancer treatment with cell reprogramming technology.

Perceptic develops modular AI software that supports scientific decision-making for biopharma research and external asset evaluation.

AbInitio Bio develops AI foundation models for biologic drug manufacturability and process optimization.

Avant Genomics is a biotechnology company that develops automated laboratory solutions for genomic and cancer research.

Tolemy Bio develops AI-driven tools to design, optimize, and control cell culture processes for advanced therapies.